AMPX Stock Price, Amprius Technologies, . Quote, Chart

Market Summary

USD1.74+0.13

Delayed

8.07%

AMPX Alerts

1 major insider sales recently.

AMPX Stock Price

View Fullscreen

AMPX RSI Chart

AMPX Valuation

Market Cap

159.4M

Price/Earnings (Trailing)

-4.33

Price/Sales (Trailing)

17.61

Price/Free Cashflow

-3.7

AMPX Price/Sales (Trailing)

AMPX Profitability

Operating Margin

-161.60%

Return on Equity

-61.5%

Return on Assets

-34.14%

Free Cashflow Yield

-27.04%

AMPX Fundamentals

AMPX Revenue

Revenue (TTM)

9.1M

Rev. Growth (Yr)

397.98%

Rev. Growth (Qtr)

40.96%

AMPX Earnings

Earnings (TTM)

-36.8M

Earnings Growth (Yr)

-60.73%

Earnings Growth (Qtr)

-14.63%

Breaking Down AMPX Revenue

Last 7 days

-1.1%

Last 30 days

-34.1%

Last 90 days

-57.8%

How does AMPX drawdown profile look like?

AMPX Financial Health

Current Ratio

3.75

AMPX Investor Care

Shares Dilution (1Y)

7.80%

Diluted EPS (TTM)

-0.43

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	3.0M	3.9M	5.9M	9.1M
2022	3.6M	4.3M	4.8M	4.4M
2021	0	4.0M	3.4M	2.8M
2020	0	0	0	4.7M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Amprius Technologies, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 12, 2024	bornstein jonathan	acquired	50,393	0.05	1,007,870	president of amprius lab
Apr 02, 2024	bornstein jonathan	acquired	6,299	0.05	125,983	president of amprius lab
Apr 02, 2024	bornstein jonathan	sold	-299,613	2.3782	-125,983	president of amprius lab
Mar 19, 2024	sun kang	acquired	-	-	1,419,670	see remarks
Mar 19, 2024	stefan constantin ionel	acquired	-	-	374,570	chief technology officer
Mar 19, 2024	bornstein jonathan	acquired	-	-	558,930	president of amprius lab
Mar 19, 2024	wallach sandra	acquired	-	-	749,700	chief financial officer
Mar 06, 2024	bornstein jonathan	sold	-111,579	2.7756	-40,200	president of amprius lab
Mar 06, 2024	bornstein jonathan	acquired	2,010	0.05	40,200	president of amprius lab
Mar 05, 2024	bornstein jonathan	sold	-320,462	2.9186	-109,800	president of amprius lab

Which funds bought or sold AMPX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 25, 2024	Bank of New York Mellon Corp	reduced	-12.24	-45,705	35,856	-%
Apr 25, 2024	SIMPLEX TRADING, LLC	new	-	66,000	66,000	-%
Apr 23, 2024	AMALGAMATED BANK	reduced	-76.22	-4,000	-	-%
Apr 19, 2024	Cutler Group LLC / CA	reduced	-24.62	-9,000	5,000	-%
Apr 12, 2024	AdvisorNet Financial, Inc	sold off	-100	-1,587	-	-%
Apr 11, 2024	DHJJ Financial Advisors, Ltd.	unchanged	-	-5,280	5,300	-%
Apr 10, 2024	Banque Cantonale Vaudoise	unchanged	-	-8,000	7,000	-%
Apr 05, 2024	CWM, LLC	new	-	-	-	-%
Mar 15, 2024	B. Riley Wealth Advisors, Inc.	added	29.3	25,622	83,450	-%
Mar 11, 2024	VANGUARD GROUP INC	added	6.14	751,345	4,821,890	-%

Are Funds Buying or Selling AMPX?

Are funds buying AMPX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AMPX

No. of Funds

AMPX Alerts

1 major insider sales recently.

Unveiling Amprius Technologies, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Oct 07, 2022	wealthspring capital llc	0.0%	0	SC 13G/A

Recent SEC filings of Amprius Technologies, Inc.

View All Filings

Date Filed	Form Type	Document
Apr 25, 2024	ARS	ARS
Apr 25, 2024	DEF 14A	DEF 14A
Apr 25, 2024	DEFA14A	DEFA14A
Apr 15, 2024	4	Insider Trading
Apr 03, 2024	4	Insider Trading
Apr 02, 2024	144	Notice of Insider Sale Intent
Apr 01, 2024	8-K	Current Report
Mar 28, 2024	S-8	Employee Benefits Plan
Mar 28, 2024	10-K	Annual Report
Mar 21, 2024	8-K	Current Report

Peers (Alternatives to Amprius Technologies, Inc.)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
CARR	54.4B	23.0B	4.89%	45.92%	40.54	2.36	9.35%	-48.07%
BLDR	22.9B	17.1B	-10.52%	103.72%	14.85	1.34	-24.77%	-43.97%
HUBB	21.8B	5.4B	-1.61%	52.51%	28.74	4.06	8.59%	39.18%
CSL	19.1B	4.8B	3.06%	84.01%	22.22	4.01	-11.35%	3.11%
LECO	13.1B	4.1B	-11.07%	40.27%	23.92	3.16	6.67%	16.79%
MID-CAP
AYI	7.8B	3.9B	-5.86%	62.59%	20.54	2.01	-6.35%	-0.40%
AAON	7.4B	1.2B	5.17%	37.79%	41.86	6.36	31.47%	76.96%
ATKR	6.7B	3.5B	-1.62%	46.02%	10.28	1.93	-10.84%	-25.77%
AEIS	3.6B	1.7B	-6.00%	12.76%	27.9	2.16	-10.27%	-35.75%
PLUG	1.6B	891.3M	-29.74%	-73.13%	-1.2	1.85	27.07%	-89.06%
SMALL-CAP
APOG	1.4B	1.4B	5.06%	47.32%	13.77	0.97	-1.65%	-4.32%
ACTG	486.5M	130.3M	-7.77%	30.21%	7.25	3.73	54.06%	153.62%
ACCO	459.5M	1.8B	-13.88%	8.52%	-21.08	0.25	-5.89%	-65.15%
FCEL	393.1M	103.0M	-25.00%	-53.97%	-4.3	3.82	-24.12%	24.29%
APT	69.9M	61.2M	-4.84%	50.62%	16.69	1.14	-1.21%	27.64%

Amprius Technologies, Inc. News

Latest updates

Amprius Technologies, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)												(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2020Q4
Revenue	41.0%	3,944,000	2,798,000	1,632,000	679,000	792,000	816,000	691,000	2,110,000	1,216,000	330,000	-	-
Cost Of Revenue	11.7%	7,869,000	7,046,000	4,664,000	4,104,000	2,502,000	2,326,000	2,055,000	3,149,000	-	1,986,000	-	-
Gross Profit	7.6%	-3,925,000	-4,248,000	-3,032,000	-3,425,000	-1,710,000	-1,510,000	-1,364,000	-1,039,000	-895,000	-1,656,000	-	-
Operating Expenses	19.2%	5,819,000	4,883,000	7,051,000	6,326,000	4,937,000	2,813,000	2,797,000	1,871,000	2,808,000	1,481,000	-	-
S&GA Expenses	11.3%	4,529,000	4,068,000	6,279,000	5,526,000	4,248,000	2,323,000	2,319,000	1,502,000	2,336,000	1,154,000	35,924	-
R&D Expenses	58.3%	1,290,000	815,000	772,000	800,000	689,000	490,000	478,000	369,000	472,000	327,000	-	-
Net Income	-14.6%	-9,734,000	-8,492,000	-9,448,000	-9,102,000	-6,056,000	-4,244,000	-4,154,000	-2,878,000	-305,104	-3,141,000	-10,102	-
Net Income Margin	27.6%	-4.06	-5.61	-7.36	-7.91	-3.93	-2.40	-2.41	-1.78	-3.57	-2.18	-1.83	-1.59
Free Cashflow	40.1%	-10,551,000	-17,609,000	-7,311,000	-7,632,000	-6,432,000	-3,245,000	-2,609,000	-3,077,000	-2,042,000	-1,637,000	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet										(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2020Q4
Assets	24.4%	108	87.00	87.00	84.00	83.00	87.00	18.00	233	19.00	-
Current Assets	-17.7%	51.00	61.00	71.00	70.00	75.00	78.00	8.00	3.00	14.00	1.00
Cash Equivalents	-14.3%	46.00	53.00	65.00	64.00	70.00	74.00	5.00	9.00	11.00	0.00
Inventory	49.9%	1.00	0.00	1.00	1.00	1.00	1.00	0.00	-	1.00	1.00
Net PPE	30.5%	22.00	17.00	7.00	5.00	4.00	4.00	4.00	-	4.00	5.00
Liabilities	129.8%	48.00	21.00	20.00	17.00	10.00	11.00	9.00	24.00	5.00	5.00
Current Liabilities	-3.0%	13.00	14.00	12.00	9.00	7.00	6.00	6.00	0.00	4.00	4.00
Shareholder's Equity	-9.1%	60.00	66.00	67.00	67.00	73.00	76.00	9.00	12.00	14.00	1.00
Retained Earnings	-8.1%	-129	-119	-111	-102	-92.89	-86.83	-82.59	-21.04	-75.40	-65.50
Additional Paid-In Capital	2.0%	189	186	178	169	166	163	91.00	-	89.00	67.00
Shares Outstanding	5.0%	89.00	85.00	85.00	85.00	85.00	69.00	66.00	66.00	66.00	66.00
Float	-	-	-	121	-	-	-	184	-	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)												(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2020Q4
Cashflow From Operations	44.7%	-4,800	-8,678	-5,583	-6,492	-5,698	-2,692	-2,449	-3,043	-1,709	-1,619	-	-
Share Based Compensation	0%	1,115	1,115	924	726	586	777	890	456	1,771	323	-	-
Cashflow From Investing	35.6%	-5,751	-8,931	-1,728	-1,140	-734	-553	-160	-34.00	-333	-18.00	-	-
Cashflow From Financing	-51.4%	2,916	5,995	8,134	2,123	2,048	71,805	-431	204	419	14,697	-	-

AMPX Income Statement

2023-12-31

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Revenue	$ 9,053	$ 4,409
Cost of revenue	23,729	10,063
Gross loss	(14,676)	(5,654)
Operating expenses:
Research and development	3,677	2,027
Selling, general and administrative	20,356	10,360
Total operating expenses	24,033	12,387
Loss from operations	(38,709)	(18,041)
Other income (expense):
Interest and other income	2,514	709
Loss on write-off of deferred stock issuance costs	(581)	0
Total other income, net	1,933	709
Net loss	$ (36,776)	$ (17,332)
Weighted-average common shares outstanding:
Weighted-average common shares outstanding, basic (in shares)	86,196,391	71,342,720
Weighted-average common shares outstanding, diluted (in shares)	86,196,391	71,342,720
Net loss per share of common stock:
Net loss per share of common stock, basic (in dollars per share)	$ (0.43)	$ (0.24)
Net loss per share of common stock, diluted (in dollars per share)	$ (0.43)	$ (0.24)

AMPX Balance Sheet

2023-12-31

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 45,761	$ 69,696
Accounts receivable	1,265	686
Inventories	730	500
Deferred costs	779	1,897
Prepaid expenses and other current assets	1,987	2,394
Total current assets	50,522	75,173
Non-current assets:
Property, plant and equipment, net	21,760	4,236
Operating lease right-of-use assets, net	35,149	2,751
Deferred costs	0	367
Other assets	305	644
Total assets	107,736	83,171
Current liabilities:
Accounts payable	3,341	1,028
Accrued and other current liabilities	5,594	2,708
Deferred revenue	3,434	2,660
Operating lease liabilities	1,088	521
Total current liabilities	13,457	6,917
Non-current liabilities:
Deferred revenue	0	720
Operating lease liabilities	34,479	2,501
Total liabilities	47,936	10,138
Commitments and contingencies (Note 11)
Stockholders’ equity:
Preferred stock; $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock; $0.0001 par value; 950,000,000 shares authorized; 88,869,463 and 84,610,114 shares issued and outstanding at December 31, 2023 and 2022, respectively	9	8
Additional paid-in capital	189,454	165,912
Accumulated deficit	(129,663)	(92,887)
Total stockholders’ equity	59,800	73,033
Total liabilities and stockholders’ equity	$ 107,736	$ 83,171

About Amprius Technologies, Inc.

Amprius Technologies, Inc. produces and sells ultra-high energy density lithium-ion batteries for mobility applications. The company offers silicon nanowire anode batteries. Its batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. The company was incorporated in 2008 and is headquartered in Fremont, California.

CEO	Dr. Kang Sun Ph.D.
WEBSITE	https://amprius.com
INDUSTRY	Communication Equipment
EMPLOYEES	72

Amprius Technologies, Inc. Frequently Asked Questions

What is the ticker symbol for Amprius Technologies, Inc.? What does AMPX stand for in stocks?

AMPX is the stock ticker symbol of Amprius Technologies, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Amprius Technologies, Inc. (AMPX)?

As of Fri Apr 26 2024, market cap of Amprius Technologies, Inc. is 159.38 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AMPX stock?

You can check AMPX's fair value in chart for subscribers.

What is the fair value of AMPX stock?

You can check AMPX's fair value in chart for subscribers. The fair value of Amprius Technologies, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Amprius Technologies, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AMPX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Amprius Technologies, Inc. a good stock to buy?

The fair value guage provides a quick view whether AMPX is over valued or under valued. Whether Amprius Technologies, Inc. is cheap or expensive depends on the assumptions which impact Amprius Technologies, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMPX.

What is Amprius Technologies, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, AMPX's PE ratio (Price to Earnings) is -4.33 and Price to Sales (PS) ratio is 17.61. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AMPX PE ratio will change depending on the future growth rate expectations of investors.